Sugargic MV 2mg/500mg/0.2mg Tablet SR
Marketer
Neorangic Healthcare Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Sugargic MV 2mg/500mg/0.2mg Tablet SR
Diabetacrin SR tablets (2mg/500mg/0.2mg) are classified as antidiabetic agents, a combination medication for adult type 2 diabetes management. This formulation helps regulate blood glucose. Diabetacrin SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continued use is crucial, even with controlled glucose levels, as abrupt cessation can elevate blood sugar, increasing risks of kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, requiring adherence to a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential preventative measures. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) are typically recommended.
Uses of Sugargic MV 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Sugargic MV 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sugargic MV 2mg/500mg/0.2mg Tablet SR whole; do not break, crush, or chew it. Administer on an empty stomach.
Common Side effects of Sugargic MV 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Sugargic MV 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Sugargic MV 2mg/500mg/0.2mg Extended-Release tablets should be taken on an empty stomach.
How Sugargic MV 2mg/500mg/0.2mg Tablet SR works:
The extended-release tablet, Sugargic MV, contains 2mg, 500mg, and 0.2mg of three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Sugargic MV 2mg/500mg/0.2mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Sugargic MV 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Sugargic MV 2mg/500mg/0.2mg tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, possibly harming the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Sugargic MV 2mg/500mg/0.2mg Tablet SR is likely unsafe for individuals with kidney impairment and should be omitted. A physician's consultation is advised. Furthermore, this medication is contraindicated in patients experiencing severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Sugargic MV 2mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dose modification. A physician's consultation is recommended. Individuals with mild to moderate liver disease should typically begin with a reduced Sugargic MV 2mg/500mg/0.2mg Tablet SR dosage; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Sugargic MV 2mg/500mg/0.2mg Tablet SR :
Should you forget to take a Sugargic MV 2mg/500mg/0.2mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sugargic MV 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently